Drug profile · INN
teplizumab-mzwv
TZIELD
teplizumab-mzwv (TZIELD) is a t-cell surface glycoprotein cd3 epsilon chain other. Route of administration: injection. Current US regulatory status: approved.
Drug details — teplizumab-mzwv
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
teplizumab-mzwv (TZIELD) is a t-cell surface glycoprotein cd3 epsilon chain other. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
T-cell surface glycoprotein CD3 epsilon chain other
Primary target: T-cell surface glycoprotein CD3 epsilon chain
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Recent coverage
FDA expands Tzield to certain pediatric patients with recent Stage 3 T1D
The FDA granted accelerated approval to Tzield for certain pediatric patients ages 8 through 17 recently diagnosed with Stage 3 type 1 diabetes. This is the first FDA-approved treatment for this indication and a key catalyst for diabetes BD and investor tracking.
Sanofi's Tzield Approved by FDA for Children as Young as 1 Year to Delay Type 1 Diabetes Progression
FDA expands Tzield approval for children aged 1+ with stage 2 type 1 diabetes, marking first disease-modifying therapy to delay insulin dependence.
FDA Approves Sanofi's Tzield for Children Age 1+ to Delay Type 1 Diabetes Onset
Sanofi's Tzield becomes first disease-modifying therapy approved for children as young as one year old to delay insulin-dependent Type 1 diabetes progression.
Related & competitor drugs
Frequently asked questions
What is teplizumab-mzwv?
teplizumab-mzwv (TZIELD) is a t-cell surface glycoprotein cd3 epsilon chain other. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for teplizumab-mzwv?
TZIELD is a marketed brand name for teplizumab-mzwv. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of teplizumab-mzwv?
teplizumab-mzwv has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.